Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Seres Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +4 vs. Q3 2022
- Shares held
- 105.1M
- +343.2K (+0.3%) vs. Q3 2022
- Total value
- $588.2M
- −$83.4M (−12.4%) vs. Q3 2022
- New holders
- 21
- 42 more added
- Sold out
- 17
- 36 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $17.9M |
| Q1 2026 | 33 | $20.5M |
| Q4 2025 | 36 | $36.4M |
| Q3 2025 | 32 | $40.9M |
| Q2 2025 | 33 | $25.4M |
| Q1 2025 | 63 | $43.1M |
| Q4 2024 | 69 | $52.5M |
| Q3 2024 | 77 | $60.1M |
| Q2 2024 | 93 | $50.0M |
| Q1 2024 | 99 | $66.3M |
| Q4 2023 | 103 | $125.4M |
| Q3 2023 | 134 | $255.6M |
| Q2 2023 | 138 | $538.1M |
| Q1 2023 | 123 | $593.9M |
| Q4 2022 | 124 | $588.2M |
| Q3 2022 | 120 | $671.6M |
| Q2 2022 | 123 | $312.7M |
| Q1 2022 | 131 | $537.2M |
| Q4 2021 | 148 | $642.8M |
| Q3 2021 | 133 | $555.1M |
| Q2 2021 | 147 | $1.93B |
| Q1 2021 | 154 | $1.85B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 304,387 | $1.71M | 0.00% | −160,324−34.5% | Reduced |
| Rafferty Asset Management, LLC | 317,511 | $1.78M | 0.01% | +112,919+55.2% | Added |
| Goldman Sachs Group Inc | 334,393 | $1.87M | 0.00% | +68,862+25.9% | Added |
| Bank of America Corp | 360,205 | $2.02M | 0.00% | +123,364+52.1% | Added |
| Silverarc Capital Management, LLC | 374,422 | $2.10M | 0.72% | +7,929+2.2% | Added |
| Renaissance Technologies LLC | 551,500 | $3.09M | 0.00% | +12,600+2.3% | Added |
| Lion Point Capital, LP | 596,803 | $3.11M | 1.86% | −30,000−4.8% | Reduced |
| Hudson Bay Capital Management LP | 580,000 | $3.25M | 0.04% | +215,100+58.9% | Added |
| Price T Rowe Associates Inc | 582,544 | $3.26M | 0.00% | +9,553+1.7% | Added |
| JPMorgan Chase & Co | 612,549 | $3.43M | 0.00% | −97,824−13.8% | Reduced |
| Charles Schwab Investment Management Inc | 636,898 | $3.57M | 0.00% | +13,838+2.2% | Added |
| Jennison Associates LLC | 668,441 | $3.74M | 0.00% | +668,441 | New |
| Point72 Asset Management, L.P. | 699,600 | $3.92M | 0.01% | −239,829−25.5% | Reduced |
| Northern Trust Corp | 730,450 | $4.09M | 0.00% | −4,031−0.5% | Reduced |
| Kynam Capital Management, LP | 776,662 | $4.35M | 0.67% | +3,842+0.5% | Added |
| Geode Capital Management, LLC | 1,590,395 | $8.91M | 0.00% | +83,901+5.6% | Added |
| Eversept Partners, LP | 2,200,999 | $12.3M | 1.17% | +265,174+13.7% | Added |
| State Street Corp | 4,564,139 | $25.6M | 0.00% | +832,618+22.3% | Added |
| Vanguard Group Inc | 6,092,937 | $34.1M | 0.00% | −517,919−7.8% | Reduced |
| BlackRock Inc. | 6,458,974 | $36.2M | 0.00% | +158,624+2.5% | Added |
| Janus Henderson Group PLC | 11,248,292 | $63.0M | 0.05% | +85,044+0.8% | Added |
| Federated Hermes, Inc. | 18,085,938 | $101.3M | 0.28% | −413,198−2.2% | Reduced |
| FMR LLC | 18,688,761 | $104.7M | 0.01% | +78,028+0.4% | Added |
| Flagship Pioneering Inc. | 23,117,045 | $129.5M | 4.13% | 00.0% | Unchanged |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −253,919−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −167,089−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −131,310−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −117,387−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −106,134−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −93,700−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −70,085−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −67,770−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −52,988−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −45,986−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −42,166−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −30,780−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −21,642−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −20,330−100.0% | Sold out |
| Cipher Capital LP | 0 | $0 | 0.00% | −15,271−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −13,937−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | 0 | Sold out |